NexImmune, Inc. (NEXI) vs Silexion Therapeutics Corp (SLXN)

NexImmune, Inc. and Silexion Therapeutics Corp are both Biotechnology companies. NexImmune, Inc. is the larger, with a market value of $1.6M against $1.4M — 1.1× the size. Across the 8 metrics below, NexImmune, Inc. leads on 5 and Silexion Therapeutics Corp on 3.

Valuation

Metric NEXI SLXN Biotechnology median
P/E n/m n/m 7.88
P/S n/m n/m 11.47
P/B n/m 4.06 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA 0.09 0.04 0.74
EV/Sales n/m n/m 10.73
Earnings yield 0.00% (8,359.54%) (28.84%)
Free cash flow yield 0.00% (6,963.95%) (23.03%)

Profitability

Metric NEXI SLXN Biotechnology median
Gross margin 0.00% — 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (232.97%) (17,021.95%) (57.72%)
Return on assets (140.56%) (277.96%) (49.22%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric NEXI SLXN Biotechnology median
Revenue growth (TTM) — — 5.64%
EPS growth (last fiscal year) 52.58% 97.73% —
Revenue growth, 5-year CAGR — — 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric NEXI SLXN Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 0.66 0.94 4.73
Net debt to EBITDA 0.10 0.38 0.96

Dividend

Metric NEXI SLXN Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric NEXI SLXN Biotechnology median
Market cap 1.60m 1.44m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack